127 related articles for article (PubMed ID: 26256892)
1. Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico.
Muñoz-Espinosa LE; Trujillo-Trujillo ME; Martínez-Macías RF; Panduro A; Rivas-Estilla AM; Fierro NA; Silvera-Linares AL; Torres-Valadez R; Cordero-Pérez P; González-Aldaco K; Chen-López CY; José-Abrego A; Zuñiga-Noriega JR; Gutiérrez-Ruiz MC; Roman S
Ann Hepatol; 2015; 14(5):642-51. PubMed ID: 26256892
[TBL] [Abstract][Full Text] [Related]
2. New findings in HCV genotype distribution in selected West European, Russian and Israeli regions.
Kartashev V; Döring M; Nieto L; Coletta E; Kaiser R; Sierra S;
J Clin Virol; 2016 Aug; 81():82-9. PubMed ID: 27367545
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Transmission Routes of Hepatitis C Virus Based on Virus Genotyping in 341 Cases with Different Suspected Initial Infection Time Points in Hunan Province, China.
Lei JH; Liang J; Gong X; Xiao XQ; Chen Z; Peng F
Med Sci Monit; 2018 Jul; 24():5232-5241. PubMed ID: 30055000
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy.
Sagnelli E; Stroffolini T; Sagnelli C; Cacopardo B; Andriulli A; Babudieri S; Coppola N; Gaeta GB; Almasio PL
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):676-681. PubMed ID: 29465473
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico.
Burguete-García AI; Conde-González CJ; Jiménez-Méndez R; Juárez-Díaz Y; Meda-Monzón E; Torres-Poveda K; Madrid-Marina V
Salud Publica Mex; 2011; 53 Suppl 1():S7-12. PubMed ID: 21877076
[TBL] [Abstract][Full Text] [Related]
6. Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern China.
Lu J; Xiang X; Cao Z; Wang W; Zhao G; Tang W; Chen L; Guo S; Zhuang Y; Shi D; Chen L; Bao S; Cai W; Wang H; Zhou H; Xie Q
J Med Virol; 2017 Nov; 89(11):1973-1980. PubMed ID: 28671305
[TBL] [Abstract][Full Text] [Related]
7. [Evolution of hepatitis C virus genotype 1a vs. 1b distribution in Germany between 2004 and 2018 - An analysis of 17093 patients from different real world registries].
Simon KG; Serfert Y; Buggisch P; Mauss S; Boeker KHW; Klinker H; Müller T; Merle U; Hüppe D; Manns MP; Wedemeyer H
Z Gastroenterol; 2021 Mar; 59(3):241-249. PubMed ID: 33684956
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of hepatitis C virus type and subtype distribution in Hungary].
Gervain J
Orv Hetil; 2018 May; 159(Suppl 2):2-8. PubMed ID: 29847988
[TBL] [Abstract][Full Text] [Related]
9. Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
Uemura H; Tsukada K; Mizushima D; Aoki T; Watanabe K; Kinai E; Teruya K; Gatanaga H; Kikuchi Y; Sugiyama M; Mizokami M; Oka S
PLoS One; 2017; 12(10):e0186255. PubMed ID: 29045448
[TBL] [Abstract][Full Text] [Related]
10. The clinical features and treatment outcome of chronic hepatitis C with pegylated interferon and ribavirin in routine care.
Tan SS; Adlin Nadia Z
Med J Malaysia; 2017 Jun; 72(3):165-174. PubMed ID: 28733564
[TBL] [Abstract][Full Text] [Related]
11. Distribution pattern of hepatitis C virus genotypes and correlation with viral load and risk factors in chronic positive patients.
Petruzziello A; Coppola N; Loquercio G; Marigliano S; Giordano M; Azzaro R; Diodato AM; Iervolino V; Di Costanzo G; Di Macchia CA; Di Meo T; Paradiso L; Ferro R; Giuliano P; Russo F; Pasquale G; Cacciapuoti C
Intervirology; 2014; 57(6):311-8. PubMed ID: 25170801
[TBL] [Abstract][Full Text] [Related]
12. All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database.
Reddy KR; Lim JK; Kuo A; Di Bisceglie AM; Galati JS; Morelli G; Everson GT; Kwo PY; Brown RS; Sulkowski MS; Akuschevich L; Lok AS; Pockros PJ; Vainorius M; Terrault NA; Nelson DR; Fried MW; Manns MP;
Aliment Pharmacol Ther; 2017 Jan; 45(1):115-126. PubMed ID: 27790729
[TBL] [Abstract][Full Text] [Related]
13. IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population.
Martínez-Gómez LE; Chávez-Tapia NC; Burguete-García AI; Aguilar-Olivos N; Madrid-Marina V; Román-Bahena M; Orbe-Orihuela C; Misael U; Méndez-Sánchez N
Ann Hepatol; 2012; 11(6):876-81. PubMed ID: 23109451
[TBL] [Abstract][Full Text] [Related]
14. Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico.
Jimenez-Mendez R; Uribe-Salas F; López-Guillen P; Cisneros-Garza L; Castañeda-Hernandez G
Ann Hepatol; 2010; 9(1):33-9. PubMed ID: 20308720
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study).
Aguilera A; Navarro D; Rodríguez-Frias F; Viciana I; Martínez-Sapiña AM; Rodríguez MJ; Martró E; Lozano MC; Coletta E; Cardeñoso L; Suárez A; Trigo M; Rodríguez-Granjer J; Montiel N; de la Iglesia A; Alados JC; Vegas C; Bernal S; Fernández-Cuenca F; Pena MJ; Reina G; García-Bujalance S; Echevarria MJ; Benítez L; Pérez-Castro S; Ocete D; García-Arata I; Guerrero C; Rodríguez-Iglesias M; Casas P; García F
J Viral Hepat; 2017 Sep; 24(9):725-732. PubMed ID: 28248445
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus genotyping in Greece: unexpected high prevalence of genotype 5a in a Greek island.
Karatapanis S; Tsoplou P; Papastergiou V; Vasiageorgi A; Stampori M; Saitis I; Tsitsopoulos E; Lisgos P; Skorda L; Ketikoglou I; Goulis I
J Med Virol; 2012 Feb; 84(2):223-8. PubMed ID: 22170541
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B.
Rosen HR; Chou S; Sasaki AW; Gretch DR
Am J Gastroenterol; 1999 Oct; 94(10):3015-9. PubMed ID: 10520862
[TBL] [Abstract][Full Text] [Related]
19. Influence of female sex on hepatitis C virus infection progression and treatment outcomes.
Corsi DJ; Karges W; Thavorn K; Crawley AM; Cooper CL
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):405-11. PubMed ID: 26745470
[TBL] [Abstract][Full Text] [Related]
20. α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response.
Tachi Y; Hirai T; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
J Gastroenterol Hepatol; 2016 May; 31(5):1001-8. PubMed ID: 27123974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
